Latest Australian Markets News

REA Group has reported a robust FY25 with strong revenue and profit growth, underpinned by solid Australian market performance and strategic moves in India. The company also announced a leadership transition amid optimistic FY26 guidance.

Following the $4.7 billion sale of its Vocus enterprise network, TPG Telecom announces a comprehensive capital management plan including a $3 billion return to shareholders, a $688 million reinvestment option, and a targeted $2.4 billion debt repayment.

Domain Holdings Australia Limited shareholders have overwhelmingly approved the proposed acquisition by CoStar Group, marking a pivotal step toward the deal’s completion pending court approval.

Argo Investments has announced a record fully franked final dividend of 20 cents per share, marking an 11.1% increase, supported by a full-year profit of $259.8 million and strong portfolio performance.

Pacific Lime and Cement Limited has made significant strides in Papua New Guinea, rebranding and advancing key projects while initiating commercial quicklime shipments to Western Australia. The company’s robust cash position and community agreements set the stage for upcoming construction milestones.

IODM Limited reported a robust 37% increase in cash receipts for Q4 FY25, driven by strong UK education sector growth and new international revenue share agreements.

Australian Vanadium Limited (AVL) reports strong progress on its integrated vanadium project, moving closer to final feasibility and advancing its utility-scale battery storage system, Project Lumina.

Stakk Limited has reported a remarkable 262% year-on-year increase in annual recurring revenue receipts, driven by its Embedded Finance services in the US and Australia. The company is poised to broaden its offerings with new client wins and the upcoming launch of Embedded Lending capabilities.

Betashares Capital Ltd has released estimated distribution amounts for 16 of its ETFs for the July 2025 period, with payments scheduled for early August. Investors are reminded of key dates and the availability of the Distribution Reinvestment Plan.

Avecho Biotechnology has ramped up recruitment in its pivotal Phase III insomnia trial and is advancing plans for regulatory approval and commercialization of its TPM®-enhanced CBD capsule, aiming to be the first over-the-counter CBD insomnia treatment in Australia.

WhiteHawk Limited reported solid Q2 revenue growth with new US contracts and is advancing its Australian market entry, while managing cash flow challenges.

Bioxyne Limited has reported record revenue and cash flow for FY25, driven by robust growth in the Australian medical cannabis market and strategic advances into Europe and the UK.